Ketamine molecule:

Image from PubChem

Ketamine Clinical Trials


Evaluation of brain glutamatergic mechanisms in patients with treatment resistant anxiety


To see complete record on anzctr.org.au, please visit this link

Id: ACTRN12617001177347p

Organisation Name: University of Otago

Overal Status: Not yet recruiting

Start Date: 01/10/2017

Brief Summary: Low-dose ketamine has fast-acting positive effects on mood in patients with treatment resistant anxiety, similar to its effects in depression. This is a mechanistic study to assess changes in brain function in patients with treatment resistant anxiety treated with ketamine or a psychoactive control, using a range of assessment methods (brain imaging, EEG analysis, blood pharmacokinetic samples). Data from this study may help clarify the neurobiological basis of treatment-resistant anxiety.

Countries:
  • New Zealand


Total execution time in seconds: 0.081577062606812